McGill University Faculty of Medicine

Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones, M.D., MPH, MBA to Chief Medical Officer and Anne-Marie Martin Ph.D. to Board of Directors

Retrieved on: 
Monday, February 28, 2022
GLOBE, Sheffield Hallam University, MD Anderson Cancer Center, Risk, Internal medicine, Board of directors, Partnership, Board, SEC, GlaxoSmithKline, Oncology, Education, Security (finance), Public health, NASDAQ, MPH, Novartis, Annual report, University, COVID-19, Hematology, Drug development, Private Securities Litigation Reform Act, Jeff, Business, Oklahoma Office of the Chief Medical Examiner, U.S. Securities and Exchange Commission, Bristol Myers Squibb, Fisher College of Business, Lymphoma, Precision medicine, Michigan Medicine, McGill University Faculty of Medicine, Lymphoid leukemia, Cancer, The Washington Campus Board of Directors, MBA, Patient, CGEM, Doctor of Philosophy, Research, Annie Martin (artist), Pharmaceutical industry, Management, Immunogenetics, Medicine, Director

The appointments of Dr. Jeff Jones as Chief Medical Officer and of Dr. Annie Martin to our Board of Directors expands our expertise within the oncology space and brings diverse perspectives to our leadership team, said Nadim Ahmed, Chief Executive Officer of Cullinan Oncology.

Key Points: 
  • The appointments of Dr. Jeff Jones as Chief Medical Officer and of Dr. Annie Martin to our Board of Directors expands our expertise within the oncology space and brings diverse perspectives to our leadership team, said Nadim Ahmed, Chief Executive Officer of Cullinan Oncology.
  • Dr. Joness successful academic tenure and deep expertise in oncology drug development will be vital to our mission to create new standards-of-care for patients with cancer.
  • I am thrilled to welcome Dr. Anne-Marie Martin to the Cullinan Oncology Board of Directors, where she will bring her experience and vision for oncology product development, said Tony Rosenberg, Chairman of the Board of Directors of Cullinan Oncology.
  • Any forward-looking statement included in this press release speaks only as of the date on which it was made.

ELNA Medical Passes a New Tech Milestone with Appointment of First Chief AI Officer

Retrieved on: 
Monday, February 21, 2022
Data science, McGill University Faculty of Medicine, MIT, McGill University, Laboratory, IBM, ELNA, Artificial intelligence, Aldo Group, Alimentation Couche-Tard, Founder, Oracle, Desautels Faculty of Management, Scale, Patient, AI, Research, Medical device

MONTREAL, Feb. 21, 2022 /CNW/ - Montreal-based ELNA Medical ("ELNA"), Canada's largest integrated network of medical clinics, announced today the appointment of Dr. Maxime Cohen as its first Chief Artificial Intelligence Officer (CAIO).

Key Points: 
  • MONTREAL, Feb. 21, 2022 /CNW/ - Montreal-based ELNA Medical ("ELNA"), Canada's largest integrated network of medical clinics, announced today the appointment of Dr. Maxime Cohen as its first Chief Artificial Intelligence Officer (CAIO).
  • Dr. Cohen joins ELNA's recently appointed chief strategy and chief technology officers in driving the company's Canada-wide tech-focused growth strategy.
  • Under Dr. Cohen's leadership, ELNA will develop a new suite of capabilities and innovative tools, leveraging disruptive AI methodologies for both patients and healthcare professionals.
  • Focused on comprehensive care, ELNA offers a vast array of primary and specialty medical services, therapies and procedures at 60-plus clinics.

The Vatican's Pontifical Council for Culture and The Cura Foundation "Unite to Prevent"

Retrieved on: 
Thursday, April 15, 2021
Medical specialties, Medicine, Ronald DePinho, Physicians, Szent-Györgyi Prize for Progress in Cancer Research, McGill University Faculty of Medicine

b'Addendum - The Fifth International Vatican Conference Speakers 2021 as of April 15:\nRabbi Elie Abadie, M.D., senior rabbi, Jewish Council of the Emirates and Association of Gulf Jewish Communities.\nAmy Abernethy, M.D., Ph.D., former principal deputy commissioner and acting chief information officer, U.S. Food and Drug Administration.\nDeepak Chopra, M.D., founder, The Chopra Foundation and founder, Chopra Global.\nGeorge Church, Ph.D., founding core faculty and lead, Wyss Institute, Harvard University; professor of genetics, Harvard Medical School; professor of health sciences and technology, Harvard and Massachusetts Institute of Technology.\nEllen Wright Clayton, M.D., J.D., Craig-Weaver Professor of pediatrics and professor of health policy, Center for Biomedical Ethics and Society, Vanderbilt University Medical Center and professor of law, Vanderbilt School of Law.\nKelly L. Close, co-founder and chair of the board, The diaTribe Foundation.\nJustin L. Barrett, Ph.D., president, Blueprint 1543, honorary professor of theology and the sciences, St. Andrews University, School of Divinity.\nNir Barzilai, M.D., The Rennert Chair of Aging Research, professor of medicine and genetics and director, Nathan Shock Center of Excellence in the Biology of Aging, Albert Einstein College of Medicine.\nJohn F. Crowley, chair of the board and CEO, Amicus Therapeutics, Inc.\nPaul Bloom, Ph.D., Brooks and Suzanne Ragen Professor of Psychology, Yale University.\nRay Dalio, founder, co-chair and co-chief information officer, Bridgewater Associates, New York Times best-selling author of "Principles: Life & Work.

Key Points: 
  • b'Addendum - The Fifth International Vatican Conference Speakers 2021 as of April 15:\nRabbi Elie Abadie, M.D., senior rabbi, Jewish Council of the Emirates and Association of Gulf Jewish Communities.\nAmy Abernethy, M.D., Ph.D., former principal deputy commissioner and acting chief information officer, U.S. Food and Drug Administration.\nDeepak Chopra, M.D., founder, The Chopra Foundation and founder, Chopra Global.\nGeorge Church, Ph.D., founding core faculty and lead, Wyss Institute, Harvard University; professor of genetics, Harvard Medical School; professor of health sciences and technology, Harvard and Massachusetts Institute of Technology.\nEllen Wright Clayton, M.D., J.D., Craig-Weaver Professor of pediatrics and professor of health policy, Center for Biomedical Ethics and Society, Vanderbilt University Medical Center and professor of law, Vanderbilt School of Law.\nKelly L. Close, co-founder and chair of the board, The diaTribe Foundation.\nJustin L. Barrett, Ph.D., president, Blueprint 1543, honorary professor of theology and the sciences, St. Andrews University, School of Divinity.\nNir Barzilai, M.D., The Rennert Chair of Aging Research, professor of medicine and genetics and director, Nathan Shock Center of Excellence in the Biology of Aging, Albert Einstein College of Medicine.\nJohn F. Crowley, chair of the board and CEO, Amicus Therapeutics, Inc.\nPaul Bloom, Ph.D., Brooks and Suzanne Ragen Professor of Psychology, Yale University.\nRay Dalio, founder, co-chair and co-chief information officer, Bridgewater Associates, New York Times best-selling author of "Principles: Life & Work.
  • "\nRichard J. Davidson, Ph.D., professor of psychology and psychiatry, and founder and director of the Center for Healthy Minds, University of Wisconsin-Madison.\nGrand Hospitaller, H.E.
  • Dominique Prince de La Rochefoucauld-Montbel, Bailiff Grand Cross of Honour and Devotion in Obedience, The Sovereign Order of Malta.\nOtis W. Brawley, M.D., Bloomberg Distinguished Professor of oncology and epidemiology, Johns Hopkins University.\nMarilyn Glassberg, M.D., division chief of pulmonary medicine, critical care and sleep medicine; senior director of clinical research for strategy and growth, department of internal medicine, University of Arizona College of Medicine.\nLaurie H. Glimcher, M.D., president and CEO, Dana-Farber Cancer Institute, Richard and Susan Smith professor of medicine, Harvard Medical School, director, Dana-Farber/Harvard Cancer Center.\nRonald A. DePinho, M.D., Distinguished University Professor and past president, MD Anderson Cancer Center.\nDr.
  • Jane Goodall, DBE, founder, the Jane Goodall Institute and U.N. Messenger of Peace.\nScott Gottlieb, M.D., resident fellow, American Enterprise Institute and 23rd commissioner, U.S. Food and Drug Administration.\nAndre Goy, M.D., physician-in-chief of Oncology Services, Hackensack Meridian Health;chair, John Theurer Cancer Center; founding chair of Oncology, Hackensack Meridian School of Medicine.\nKurt J. Griffin, M.D., Ph.D., Todd and Linda Broin Chair for Diabetes Research; director of clinical trials, The Sanford Project, Sanford Research; and associate professor, pediatric endocrinology, Sanford School of Medicine, University of South Dakota.\nMichael E. Farkouh, M.D., Peter Munk Chair in Multinational Clinical Trials; director, Heart & Stroke/Richard Lewar Centre of Excellence; vice-chair, research and professor of medicine, department of medicine, University of Toronto.\nPaul Farmer, M.D., Ph.D., Kolokotrones University professor and chair, department of global health and social medicine, Harvard Medical School; co-founder and chief strategist, Partners In Health.\nAnthony S. Fauci, M.D., director, National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health.\nDonald Hoffman, Ph.D., professor emeritus of cognitive sciences, University of California, Irvine.\nRev.